These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. State of the art: radiolabeled microspheres treatment for liver malignancies. Deleporte A; Flamen P; Hendlisz A Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269 [TBL] [Abstract][Full Text] [Related]
3. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors. Riaz A; Lewandowski RJ; Kulik L; Salem R Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310 [TBL] [Abstract][Full Text] [Related]
4. Radioembolization of liver tumors with yttrium-90 microspheres. Ahmadzadehfar H; Biersack HJ; Ezziddin S Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679 [TBL] [Abstract][Full Text] [Related]
5. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840 [TBL] [Abstract][Full Text] [Related]
6. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization). Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635 [TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres. Sangro B; Bilbao JI; Iñarrairaegui M; Rodriguez M; Garrastachu P; Martinez-Cuesta A Dig Dis; 2009; 27(2):164-9. PubMed ID: 19546555 [TBL] [Abstract][Full Text] [Related]
8. Yttrium-90 radioembolization in the management of liver malignancies. Riaz A; Kulik LM; Mulcahy MF; Lewandowski RJ; Salem R Semin Oncol; 2010 Apr; 37(2):94-101. PubMed ID: 20494701 [TBL] [Abstract][Full Text] [Related]
9. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness. Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684 [TBL] [Abstract][Full Text] [Related]
10. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors. Van De Wiele C; Defreyne L; Peeters M; Lambert B Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):317-24. PubMed ID: 19521311 [TBL] [Abstract][Full Text] [Related]
11. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231 [TBL] [Abstract][Full Text] [Related]
12. Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. Hong K; McBride JD; Georgiades CS; Reyes DK; Herman JM; Kamel IR; Geschwind JF J Vasc Interv Radiol; 2009 Mar; 20(3):360-7. PubMed ID: 19167245 [TBL] [Abstract][Full Text] [Related]
13. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives]. Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591 [TBL] [Abstract][Full Text] [Related]
14. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416 [TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 internal radiation therapy for hepatic malignancy. Garrean S; Joseph Espat N Surg Oncol; 2005 Dec; 14(4):179-93. PubMed ID: 16527479 [TBL] [Abstract][Full Text] [Related]
16. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Gaba RC; Lewandowski RJ; Kulik LM; Riaz A; Ibrahim SM; Mulcahy MF; Ryu RK; Sato KT; Gates V; Abecassis MM; Omary RA; Baker TB; Salem R Ann Surg Oncol; 2009 Jun; 16(6):1587-96. PubMed ID: 19357924 [TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil. Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170 [TBL] [Abstract][Full Text] [Related]
18. Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors. Kennedy AS; McNeillie P; Dezarn WA; Nutting C; Sangro B; Wertman D; Garafalo M; Liu D; Coldwell D; Savin M; Jakobs T; Rose S; Warner R; Carter D; Sapareto S; Nag S; Gulec S; Calkins A; Gates VL; Salem R Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1494-500. PubMed ID: 19157721 [TBL] [Abstract][Full Text] [Related]
19. Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies. Jones A; Alexander HR Surg Oncol Clin N Am; 2008 Oct; 17(4):857-76, x. PubMed ID: 18722923 [TBL] [Abstract][Full Text] [Related]